Background--Cross-sectional clustering of metabolic risk factors for cardiovascular disease in middle-aged adults is well described, but less is known regarding the order in which risk factors develop through young adulthood and their relation to subclinical atherosclerosis.
C ardiovascular risk factors have been observed to cluster in youth, 1,2 young adulthood, 3 and middle age, 4 and the presence of additional risk factors has been shown to increase risk of subclinical atherosclerosis development in young and middle-aged adults 5, 6 and risk of clinical cardiovascular disease in middle age. 4 It is not clear, however, which risk factors appear first and which are potentially early markers of subsequent additional risk, especially in the window between young adulthood and middle age. Similarly, multiple studies have examined the subset of risk factors known as the metabolic syndrome; these risk factors have been observed to cluster together consistently over time, 7 but less is known about accrual order. Recent data have suggested that the order of accumulation in middle age is associated with clinical outcomes. 8 Interrelations between pairs of cardiovascular risk factors have also been studied extensively. Weight gain has been shown to be associated with changes in lipids, increases in fasting glucose, and increases in blood pressure in young adults. 9 Hypertension has been associated with incident diabetes, 10 and insulin resistance has been associated with incident hypertension.
11
Other studies have observed an increase in incident diabetes 12 and incident hypertension 13 following abnormal lipid levels. This study aimed to identify patterns in the accrual of major metabolic cardiovascular risk factors in black and white women and men throughout young adulthood to middle age and to examine the relationship of these patterns with subclinical atherosclerosis. We used data from the Coronary Artery Risk Development in Young Adults (CARDIA) study, which included 20 years of follow-up, to measure and examine patterns of cardiovascular risk factor accrual overall and by race, sex, and smoking status.
Methods

Study Population
The CARDIA study enrolled 5115 black and white women and men from 4 US sites.
14 Baseline (1985 Baseline ( -1986 ) recruitment procedures were designed to balance age, sex, ethnicity, and education groups within each of 3 US communities studied (Birmingham, Alabama; Minneapolis, Minnesota; and Chicago, Illinois) and a health insurance company based in Oakland, California. Participants were aged 18 to 30 years at baseline and were followed up for 20 years, with examinations at baseline (year 0) and at years 2, 5, 7, 10, 15, and 20, with a retention rate of 72% of the surviving cohort at year 20. All participants provided informed consent at each examination, and all study protocols were approved by the institutional review board at each center. We excluded participants for whom complete risk factor information was not available at the year 20 examination (1935 participants) and excluded those who had all 5 metabolic risk factors at baseline (1 participant), leaving 3178 participants.
Risk Factors
We focused on 5 metabolic risk factors for cardiovascular disease: hypertension, hypercholesterolemia, dyslipidemia, diabetes, and obesity. Blood pressure was measured 3 times at each examination, according to previously published protocols. 14 The average systolic and diastolic pressures from the last 2 measurements were used. Participants were classified as having hypertension at the first visit at which they had elevated blood pressure (≥140 mm Hg systolic or ≥90 mm Hg diastolic) or reported use of antihypertensive medication. Total cholesterol, low-density lipoprotein cholesterol, triglycerides, and high-density lipoprotein cholesterol (HDL-C) were measured at each visit from a fasting blood sample processed at a central laboratory. 14, 15 Participants were classified as having hypercholesterolemia at the first visit at which total cholesterol was ≥240 mg/dL, low-density lipoprotein cholesterol was >160 mg/dL, or use of cholesterollowering medications was reported (for years 5 through 20). 16 Patients were classified as having dyslipidemia at the first visit at which HDL-C was <50 mg/dL in women or <40 mg/dL in men or triglyceride levels were >200 mg/dL in either sex. Blood glucose was measured from fasting blood samples at baseline and at years 7, 10, 15, and 20.
14 Patients were asked at all visits about medication use and diagnosis of diabetes. Participants were classified as having diabetes at the first visit with fasting blood glucose ≥126 mg/dL (when available), reported use of diabetes medication, or reported physician diagnosis of diabetes. Weight, height, and waist circumference were also measured at each study visit, with participants wearing light clothing, and body mass index was calculated as the weight in kilograms divided by height in square meters. Participants were classified as obese at the first visit at which body mass index was ≥30 or waist circumference was >88 cm in women or >102 cm in men.
Information on smoking, including whether the participant was currently smoking and the number of cigarettes smoked per day, was collected at each study visit. In addition, prior smoking information was collected at baseline. Using previously defined methods for this cohort, cumulative exposure to cigarettes in pack-years was calculated for each participant. 17 
Subclinical Cardiovascular Disease
Coronary artery calcium (CAC) was measured at year 20 using computed tomography scanning with 2 scans for each participant. 18 All scans were analyzed by cardiovascular radiologists blinded to participant characteristics, with high within-and between-reader reliability. Summary Agatston scores were calculated and dichotomized for this analysis into any calcification (score >0) or no calcification (score 0). Carotid intima-media thickness (CIMT) was measured at year 20 using the average of 4 ultrasound images measuring the maximum thickness of the common carotid artery. 19 A total of 2577 participants had information available on CAC and CIMT.
Statistical Methods
Risk factor accumulation was calculated by examining each participant's visit history. Visits were included if the status of all risk factors could be determined and if the participant did not report being pregnant at the time of the visit. Participants were classified into groups according to the order in which risk factors developed during follow-up. A participant who, for example, first developed obesity and then developed hypertension but no additional risk factors was placed in the obesity/ hypertension group. There were 326 possible groups: 120 with 5 risk factors, 120 with 4 risk factors, 60 with 3 risk factors, 20 with 2 risk factors, 5 with 1 risk factor, and 1 with none. Weighted values corresponding to the probability of each combination were used when the order of risk factor development was unclear. A participant who had no risk factors at baseline, hypertension at year 2 and dyslipidemia at year 7 would contribute full weighted value to the hypertension/ dyslipidemia group. A participant who had no risk factors at baseline and hypertension and dyslipidemia simultaneously at year 2 would contribute 0.5 of their weighted value to each of the hypertension/dyslipidemia and dyslipidemia/hypertension groups.
The overall (or marginal) probability of developing each risk factor over the 20-year follow-up period was calculated, and these probabilities were used to obtain the expected joint probabilities of each combination under the null hypothesis of risk factor independence. Similarly, the expected probabilities of combinations of risk factors and conditional probabilities were also obtained.
These expected probabilities were then compared with the observed rates for each question under examination. For example, to examine whether hypertension or dyslipidemia occurs first when they are both present, we restricted our analysis to the set of participants with hypertension and dyslipidemia. Although dyslipidemia occurs more frequently than hypertension in the population, within our restricted set, both were equally likely to occur (with probability of 100%). Under our null hypothesis, each factor has a uniform rate of occurrence throughout the follow-up period, meaning that hypertension or dyslipidemia could have occurred at any point in the follow-up, and each were equally likely to have occurred first. We then compared the observed rate of hypertension occurring first to the expected rate of 50%. All observed and expected probabilities were compared using a chi-square test of proportions.
For participants with CIMT measures at year 20, we generated expected CIMT values predicted by sex, race, age, and smoking status at year 15 and pack-years smoked using a linear model and subtracted these from the individual observed values to obtain the residual CIMT for each participant. These residuals were then combined using the weighting for each sequence to obtain the mean residual for each accumulation combination or conditional group. The mean residual for each group was compared with the expected mean residual CIMT of 0. A similar process was followed for those participants with measured CAC at year 20. We generated the expected probability of any CAC predicted by sex, race age, and smoking status and pack-years for each participant. Weighted average expected probabilities were obtained for each group and compared with the observed prevalence of CAC.
To further describe the associations within subgroups, we performed the analyses stratified by race and sex categories BMI indicates body mass index; HDL, high-density lipoprotein; LDL, low-density lipoprotein; WC, waist circumference. *Criteria are assessed hierarchically in the order displayed (ie, once assigned to a criterion, a participant is no longer evaluated for remaining criteria). and by smoking status. We also performed an analysis using the ATP III metabolic syndrome criteria, 16 In this analysis, the cutoffs were changed to ≥110 mg/dL for fasting glucose, ≥150 mg/dL for triglycerides, and ≥130 mm Hg for systolic blood pressure. All analyses were performed using R 2.10.0 (R Foundation). A 2-tailed P value of <0.05 was considered statistically significant for each comparison in this analysis because the results were meant to be hypothesis generating. The main results (Tables 2 through 4) include 30 comparisons in all, so a Bonferroni adjusted cutoff of 0.0017 could be used for those tables and would provide similar results.
Results
Of the 3178 participants, 57% were female and 46% were black. At baseline, the mean age was 25.1 years, with 25.6% current smokers and 14.4% former smokers. This group was more likely to be female, white, and nonsmokers than the CARDIA cohort members who were not included (mean age 24.5 years, 51% female, 62% black, 13% former smokers, and 40% current smokers). After 20 years, 26.1% of participants had hypertension, 25.8% had hypercholesterolemia, 55.4% had dyslipidemia, 8.7% had diabetes, and 46.0% were obese. More information on the definition of each risk factor is given in Table 1 . Of note, 89% of dyslipidemia was identified by low HDL-C levels alone, and 5% had low HDL-C and elevated triglycerides.
Risk Factor Accumulation
Of the 326 potential sequences of accumulation for the 5 risk factors, 280 were observed in our data. The sequence in which no risk factors developed occurred 1.9 times as often as expected, suggesting that risk factors clustered rather than sorting independently. Among sequences with at least 1 risk factor, when the association between a risk factor occurring first and subsequent risk factor accumulation was examined (Table 2) , we found that the probability of accumulating at least 1 additional risk factor was significantly greater than expected for dyslipidemia and obesity (1.1 times as much accumulation of other risk factors observed versus expected for both). In contrast, hypertension and diabetes occurring first were followed by an additional risk factor only 0.8 time as often as expected. Accumulation following hypercholesterolemia did not occur significantly more or less than expected.
Risk Factor Order
We next looked at the order within sequences that had at least 2 risk factors. The expected probability of a risk factor occurring first depended only on the number of risk factors in each sequence, for example, for all sequences of 3 risk factors that include hypertension, hypertension should be first in one-third of them. As shown in Table 3 , when dyslipidemia was included in a sequence, it occurred first 1.3 times more often than expected. Conversely, diabetes occurred first in a sequence less often than expected (0.3 times as often as expected), as did hypertension (0.4), obesity (0.8) and hypercholesterolemia (0.9). We also examined the occurrence of pairs of risk factors in a sequence, which included sequences with only the pair of risk factors and those with both the pair and additional risk factors (Table 4) . Most pairs occurred more often than expected under random accrual, with the largest ratio of observed to expected in dyslipidemia/hypertension (4.0 times more often than expected); however, dyslipidemia/diabetes and dyslipidemia/hypercholesterolemia occurred significantly less often than expected. When we examined the order in which each pair occurred, dyslipidemia was more likely to occur before any other risk factor. Hypercholesterolemia was significantly more likely to occur before diabetes and hypertension; however, hypercholesterolemia and obesity were not more likely to occur in either order, and neither were hypertension and diabetes. Obesity was more likely to occur prior to diabetes and hypertension.
Relationship of Order With Presence of CAC or CIMT
No pairs of risk factors were associated with a significantly higher prevalence of CAC than expected from participant age, sex, race, smoking behavior at year 20, and pack-years at year 20. Similarly, no pairs of risk factors were associated with higher mean CIMTs than expected from participant age, sex, race, number of risk factors, smoking behavior at year 20, and pack-years at year 20.
Results for Additional Analysis
Separate analysis by sex, race, and smoking status at baseline resulted in similar patterns, with some relationships becoming nonsignificant because of smaller sample sizes (Tables 5  through 7) . Results were also similar when the metabolic syndrome cut points were used (Tables 8 through 11 ). 
Discussion
In this cohort study of 3178 young black and white women and men, we found that dyslipidemia-primarily low HDL-C but also including high triglyceride levels-was more likely to occur first in a sequence or in a pair with any other risk factor, and accumulation of other risk factors was more likely when dyslipidemia occurred first. Hypertension, hypercholesterolemia, obesity, and diabetes were less likely than expected to occur first in a sequence, although obesity and hypercholesterolemia occurred first more often in pairs with hypertension and diabetes. Hypertension and diabetes were also less likely to be followed by additional risk factors. These results were similar when stratified by sex, race, and smoking status at baseline and suggest that dyslipidemia screening in early adulthood may be a good target for early prevention of cardiovascular risk factor accumulation.
Our results complement previous findings that dyslipidemia, specifically low HDL-C, precedes development of other metabolic risk factors including insulin resistance, hypertension, and abdominal adiposity. 8 Our results are also consistent with other studies showing lipid abnormalities prior to hypertension and diabetes. In the Women's Health Study cohort, the lowest quintile of HDL-C levels was associated with a 4-fold increase in incident diabetes compared with the highest quintile, even after adjustment for other risk factors, whereas the highest quintile of triglyceride levels was associated with a 3.7-fold increase in risk compared with the lowest quintile. 20 In the same cohort, low HDL-C was also associated with an increased risk of incident hypertension after adjustment for other risk factors (hazard ratio 1.23 for lowest quintile compared with highest), as were high triglyceride levels (hazard ratio 1.53 for highest quintile compared with lowest). 13 Both studies also suggest that there may be additional information in the lipoprotein particle sizes, with stronger associations in small HDL-C particles and larger triglyceride-rich particles. Our results examining all risk factors simultaneously, suggest that HDL-C and triglycerides are early markers of underlying metabolic dysfunction leading to additional cardiovascular disease risk factor accumulation and increased cardiovascular disease risk. Strengths of our study include the ability to assess cardiovascular risk factor development in early adulthood, which is a critical period of risk development. We also had multiple visits with high-quality repeated measures over 20 years to obtain risk factor information. Risk factors were directly measured using standardized methods, which reduce the risk of ascertainment bias. We were not able to calculate the exact timing of risk factor accrual, leaving residual ambiguity in our calculations, nor was enough follow-up time available to assess hard cardiovascular outcomes. We limited this analysis to dichotomous measures of risk factors and did not examine reduction in risk factors at subsequent visits, and we did not examine the effects of risk factor treatment. The analysis was also limited to those who had complete risk factor information at the 20-year visit, potentially limiting the generalizability of the results. In addition, there was no information on other ethnic groups, such as Asian populations, which may have different patterns of risk factors accumulation; however, the study population included black and white women and men, and stratified analyses were similar to the overall results.
Conclusions
Our results suggest that dyslipidemia, primarily due to low HDL-C but also including elevated triglyceride levels, may precede development of other established cardiovascular risk factors. Screening for dyslipidemia and continuing follow-up of for those young adults who develop dyslipidemia may provide an opportunity for lifestyle interventions. DIAB indicates diabetes; DYSL, dyslipidemia; HCL, hypercholesterolemia; HTN, hypertension; OBST, obesity. *The expected value is generated as follows: For the risk factor DYSL, the expected probability of DYSL occurring first would be (1/2)9(the number of participants with 2 risk factor combinations that include DYSL)+(1/3)9(the number of participants with 3 risk factor combinations that include DYSL)+(1/4)9(the number of participants with 4 risk factor combinations that include DYSL)+(1/5)9(the number of participants with 5 risk factor combinations that include DYSL). DIAB indicates diabetes; DYSL, dyslipidemia; HCL, hypercholesterolemia; HTN, hypertension; OBST, obesity. *Risk factors do not have to be directly contiguous in time, for example, a sequence of diabetes followed by hypercholesterolemia and then hypertension would contribute to the HTN and DIAB row as a combination but not to the percentage in the listed order, to the HCL and DIAB row as a combination but not to the percentage in the listed order, and to the HCL and HTN row as both a combination and as part of the percentage in the listed order.
